| 臺大學術典藏 |
2020-09-30T08:49:25Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L.; Shyu K.-G.; Chao T.-H.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chen J.-F.; Yeh H.-I.; Wang T.-D.; Lin T.-H.; Lin S.-Y.; Chiang C.-E. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J.; Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I. |
| 臺大學術典藏 |
2020-09-28T02:48:03Z |
Efficacy and safety of olmesartan in the treatment of mild-to-moderate essential hypertension in chinese patients
|
Liau C.-S.;Lee C.-M.;Sheu S.-H.;Ueng K.-C.;Chien K.-L.;Ta-Chen Su;Lai W.-T.;Lin M.-C.;Lin C.-S.;Lin C.-S.; Liau C.-S.; Lee C.-M.; Sheu S.-H.; Ueng K.-C.; Chien K.-L.; TA-CHEN SU; Lai W.-T.; Lin M.-C.; Lin C.-S.; Lin C.-S. |
| 臺大學術典藏 |
2020-06-01T09:06:40Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Chih-Yuan Wang;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Tang S.-C.;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; CHIH-YUAN WANG; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Yeh H.-I.; Wu C.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:19Z |
An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in Chinese patients with mild to moderate hypertension
|
Ueng K.-C.; Lin L.-C.; Voon W.-C.; Lin M.-C.; Liu Y.-B.; Su H.-M.; Chang P.-Y.; Lin T.-H.; Chen W.-L.; CHAU-CHUNG WU; Lai W.-T.; Lin C.-S. |
| 臺大學術典藏 |
2020-03-04T09:03:13Z |
2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the diagnosis and treatment of heart failure
|
Wang C.-C.; Chen J.-H.; Yu W.-C.; Cheng J.-J.; Yin W.-H.; CHAU-CHUNG WU; Li A.-H.; Lin W.-S.; Chen P.-S.; Ueng K.-C.; Huang J.-L.; Tsai F.-C.; Wang C.-H.; Fu T.-C.; Liu M.-H.; Chen P.-R.; Pai H.-Y.; Cherng W.-J. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T05:42:45Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:38Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:57Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:46Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-02-27T07:43:24Z |
Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms
|
Ueng K.-C.; Lei M.-H.; Tsao H.-M.; Chen S.-A.; Lin T.-K.; Wu M.-H.; Lo H.-M.; Huang S.K.S.; Lin J.-L.; Lin J.-L.;Huang S.K.S.;Lo H.-M.;Wu M.-H.;Lin T.-K.;Chen S.-A.;Tsao H.-M.;Lei M.-H.;Ueng K.-C.;Wu T.-J.;Ko Y.-L.;Wang C.-C.;Yeh S.-J.;WEN-JONE CHEN;Ho Y.-L.;Liu Y.-B.;Juang J.-M.;Chiang F.-T.;Su Y.-N.;Lai L.-P.; Lai L.-P.; Su Y.-N.; Chiang F.-T.; Juang J.-M.; Liu Y.-B.; Ho Y.-L.; WEN-JONE CHEN; Yeh S.-J.; Wang C.-C.; Ko Y.-L.; Wu T.-J. |
| 臺大學術典藏 |
2020-02-27T07:43:16Z |
Erratum: Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms (Journal of Human Genetics (2005) 50 (490-496) DOI: 10.1007/s10038-005-0283-3)
|
Lin J.-L.;Huang S.K.S.;Lo H.-M.;Wu M.-H.;Lin T.-K.;Chen S.-A.;Tsao H.-M.;Lei M.-H.;Ueng K.-C.;Wu T.-J.;Ko Y.-L.;Wang C.-C.;Yeh S.-J.;WEN-JONE CHEN;Ho Y.-L.;Liu Y.-B.;Juang J.-M.;Chiang F.-T.;Hsieh F.-J.;Su Y.-N.;Lai L.-P.; Lai L.-P.; Su Y.-N.; Hsieh F.-J.; Chiang F.-T.; Juang J.-M.; Liu Y.-B.; Ho Y.-L.; WEN-JONE CHEN; Yeh S.-J.; Wang C.-C.; Ko Y.-L.; Wu T.-J.; Ueng K.-C.; Lei M.-H.; Tsao H.-M.; Lin J.-L.; Huang S.K.S.; Lo H.-M.; Wu M.-H.; Chen S.-A.; Lin T.-K. |
| 臺大學術典藏 |
2020-02-27T07:42:46Z |
2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
|
Chiang C.-E.; Wang T.-D.; Ueng K.-C.; Lin T.-H.; Yeh H.-I.; Chen C.-Y.; Wu Y.-J.; Tsai W.-C.; Chao T.-H.; Chen C.-H.; Chu P.-H.; Chao C.-L.; Liu P.-Y.; Sung S.-H.; Cheng H.-M.; Wang K.-L.; Li Y.-H.; Chiang F.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Lin S.-J.; Lin S.-J.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Chiang F.-T.;Li Y.-H.;Wang K.-L.;Cheng H.-M.;Sung S.-H.;Liu P.-Y.;Chao C.-L.;Chu P.-H.;Chen C.-H.;Chao T.-H.;Tsai W.-C.;Wu Y.-J.;Chen C.-Y.;Yeh H.-I.;Lin T.-H.;Ueng K.-C.;Wang T.-D.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-27T07:42:38Z |
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
|
Chiang C.-E.; Wu T.-J.; Ueng K.-C.; Chao T.-F.; Chang K.-C.; Wang C.-C.; Lin Y.-J.; Yin W.-H.; Kuo J.-Y.; Lin W.-S.; Tsai C.-T.; Liu Y.-B.; Lee K.-T.; Lin L.-J.; Lin L.-Y.; Wang K.-L.; Chen Y.-J.; Chen M.-C.; Cheng C.-C.; Wen M.-S.; WEN-JONE CHEN; Chen J.-H.; Lai W.-T.; Chiou C.-W.; Lin J.-L.; Yeh S.-J.; Chen S.-A.; Chen S.-A.;Yeh S.-J.;Lin J.-L.;Chiou C.-W.;Lai W.-T.;Chen J.-H.;WEN-JONE CHEN;Wen M.-S.;Cheng C.-C.;Chen M.-C.;Chen Y.-J.;Wang K.-L.;Lin L.-Y.;Lin L.-J.;Lee K.-T.;Liu Y.-B.;Tsai C.-T.;Lin W.-S.;Kuo J.-Y.;Yin W.-H.;Lin Y.-J.;Wang C.-C.;Chang K.-C.;Chao T.-F.;Ueng K.-C.;Wu T.-J.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-27T07:42:37Z |
The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension
|
Lin J.-L.; Lin J.-L.;Lin S.-J.;Chen M.-F.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Lai W.-T.;Chiang F.-T.;Wang K.-Y.;Li Y.-H.;Wang K.-L.;Sung S.-H.;Chu P.-H.;Chen C.-Y.;Ueng K.-C.;Shyu K.-G.;Chen C.-H.;Chao T.-H.;Cheng H.-M.;Liu P.-Y.;Yeh H.-I.;Lin T.-H.;Wang T.-D.;Chiang C.-E.; Chiang C.-E.; Wang T.-D.; Lin T.-H.; Yeh H.-I.; Liu P.-Y.; Cheng H.-M.; Chao T.-H.; Chen C.-H.; Shyu K.-G.; Ueng K.-C.; Chen C.-Y.; Chu P.-H.; Sung S.-H.; Wang K.-L.; Li Y.-H.; Wang K.-Y.; Chiang F.-T.; Lai W.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Chen M.-F.; Lin S.-J. |
| 臺大學術典藏 |
2020-02-20T02:56:56Z |
Molybdenum induces pancreatic β-cell dysfunction and apoptosis via interdependent of JNK and AMPK activation-regulated mitochondria-dependent and ER stress-triggered pathways
|
Wu C.-C.; Hsieh S.-S.; Ueng K.-C.; Huang C.-F.; Huang C.-F.;Ueng K.-C.;Hsieh S.-S.;Wu C.-C.;CHING-YAO YANG;Su C.-C.;Lee K.-I.;Yen C.-C.;Yang T.-Y.; Yang T.-Y.; Yen C.-C.; Lee K.-I.; Su C.-C.; CHING-YAO YANG |
| 國立成功大學 |
2020 |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang, Chiang C.-E.;Ueng, K.-C.;Chao, T.-H.;Lin, T.-H.;Wu, Y.-J.;Wang, K.-L.;Sung, Sung S.-H.;Yeh, H.-I.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Shyu, K.-G.;Huang, J.-L.;Tsai, C.-D.;Hung, Hung H.-F.;Liu, M.-E.;Chao, T.-F.;Cheng, S.-M.;Cheng, H.-M.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Chen, W.-J.;Lai, W.-T.;Lin, S.-J.;Yeh, S.-J.;Hwang, J.-J. |
| 臺大學術典藏 |
2019-07-09T08:15:05Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients;Yeh H.-I.;Wu C.-C.;Chen J.-W.;Yu T.-Y.;Lee C.-C.;Tang S.-C.;Liou C.-W.;Chien S.-C.;Su C.-H.;Liu P.-Y.;Chao T.-H.;Wang C.-Y.;Kuo-Liong Chien;Lin T.-H.;Charng M.-J.;Jeng J.-S.;Ueng K.-C.;Li Y.-H.; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; KUO-LIONG CHIEN; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2019-05-24T03:00:35Z |
Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis
|
Jong, C.-B.; Chen, K.-Y.; HSIEH MU-YANG; Su, F.-Y.; WU CHIH-CHENG; Voon, W.-C.; Hsieh, I.-C.; Shyu, K.-G.; Chong, J.-T.; Lin, W.-S.; Hsu, C.-N.; Ueng, K.-C.; LAI, CHAO-LUN; Ueng, K.-C.;Hsu, C.-N.;Chong, J.-T.;Shyu, K.-G.;Hsieh, I.-C.;Voon, W.-C.;Wu, C.-C.;Su, F.-Y.;Hsieh, M.-Y.;Chen, K.-Y.;Jong, C.-B.;Lin, W.-S.;LAI, CHAO-LUN |
| 臺大學術典藏 |
2019 |
Gender difference in clinical and genetic characteristics of Brugada syndrome: SADS-TW BrS registry
|
Feng W.-J.; Chang S.-X.; Lei M.-H.; Ko W.-C.; Kong C.-W.; Kuo C.-T.; Huang B.-X.; Li K.-T.; Chen W.-D.; Luo J.-L.; Lin J.-Y.; Tsai T.-N.; Hsu C.-T.; Lin L.-R.; Chen R.-Y.; Li P.-T.; Stephen Huang S.K.; SADS-TW BrS Registry; Chang J.-R.; Ye G.-H.; Chiu W.-R.; Liu Z.-Z.; Lin H.-H.; Liao Y.-C.; Li C.-H.; Hsieh Y.-C.; Chua S.-K.; Lin M.-T.; Chiu S.-N.; Horie M.; Wu M.-H.; Wu T.-J.; Chen S.-A.; Wang C.-C.; Chang K.-C.; Feng A.-N.; Lin Y.-J.; Ueng K.-C.; Tsao H.-M.; Huang J.-L.; Tsai W.-C.; Tsai C.-F.; Chang S.-L.; Lo L.-W.; Hu Y.-F.; Chung F.-P.; Chang C.-J.; Lo H.-M.; Chiang M.-C.; Hsia C.-P.; Liu J.-F.; Chen C.-Y.J.; Juang J.-M.J.; LIAN-YU LIN; Liu Y.-B.; Ho L.-T.; Yu C.-C.; Huang H.-C.; Lin T.-T.; Liao M.-C.; Chen J.-J.; Hwang J.-J.; Chen W.-J.; Yeh S.-F.S.; Yang D.-H.; Chiang F.-T.; Lin J.-L.; Lai L.-P. |
